Berberine Repairs Intestinal Mucosal Barrier by Targeting HSP90AA1 and MAPK14
BBR inhibits the expression of HSP90AA1 and MAPK14 both in vitro and in vivo, thereby facilitating the repair of the intestinal mucosal barrier.
Authors
- Yao Huang (ORCID: https://orcid.org/0000-0002-7247-7786)
- Dongya Chen (ORCID: https://orcid.org/0000-0001-8548-9869)
- Shengpeng Shao
- Danya Zhao (ORCID: https://orcid.org/0000-0003-2329-4390)
- Jianlong Shu
- Chen Chen (ORCID: https://orcid.org/0000-0002-3485-1618)
- Junkang Chen (ORCID: https://orcid.org/0009-0009-3939-0708)
- Zhexuan Yu
- Yuelin Zhai (ORCID: https://orcid.org/0009-0009-4932-7737)
- Qiang Yang (ORCID: https://orcid.org/0000-0001-8731-3533)
Institutions
- Zhejiang Chinese Medical University (CN)
- Jining Traditional Chinese Medicine Hospital (CN)
- The Second Nanning People's Hospital (CN)
- First People's Hospital of Nanning (CN)
- Hangzhou Red Cross Hospital (CN)
Publication Details
- Journal
- Pharmacogenomics and Personalized Medicine
- Published
- 2025-11-01
- DOI
- https://doi.org/10.2147/pgpm.s547308
- Primary Topic
- Berberine and alkaloids research
- Type
- article
- Field-Weighted Citation Impact
- 0.00